DAVID LOWE: Open Payments
NPI 1770536062 · ROCHESTER, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 19 payments from 11 companies in 2025. Trend: 2023 $124 · 2024 $106 · 2025 $344
Food & beverage: $284Education: $34Consulting: $26
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $47 |
| CSL Behring | 1 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| ADMA BioManufacturing LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Electromed, Inc. | 3 | $20 |
| GENZYME CORPORATION | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: DUPIXENT, NEFFY, Hizentra, AIRSUPRA, Rhapsido, SMARTVEST, TEZSPIRE, FASENRA.
Industry payments across MN — which companies pay providers there.
